DeMarco Richard A, Fink Mitchell P, Lotze Michael T
Department of Surgery, Molecular Medicine Institute, University of Pittsburgh School of Medicine, Pittsburgh, PA 15219, USA.
Mol Immunol. 2005 Feb;42(4):433-44. doi: 10.1016/j.molimm.2004.07.023.
Substantial attention has been paid to the role of the toll-like receptor (TLR) ligands of late and their role in regulating the innate immune response. They serve as exogenous danger signals important in informing and driving the distal adaptive immune response to pathogens. Less clear has been the role of the nominal endogenous danger signals released and recognized in stressed cells following genotoxic or metabolic stress as occurs in progressively growing tumors. HMGB1 (high-mobility group B1) is a nuclear protein well characterized for its ability to modify DNA access to transcriptional proteins that is released from necrotic cells as well as secreted through the endosomal route from hematopoietic cells, serving as a late mediator of sepsis. It interacts with high-affinity RAGE (receptor for advanced glycation end products) and TLR2 receptors. Here we show that HMGB1 enhances interferon gamma release from macrophage (but not dendritic cell)-stimulated NK cells. This is effective only when coupled with other pro-inflammatory cytokines particularly with IL-2 in combination with IL-1 or IL-12. We have used this information to suggest that HMGB1, which also promotes epithelial migration and proliferation, drives repair in the absence or inhibition of other factors but enhances inflammation in their presence. The implications for tumorigenesis and tumor progression are quite important as they may be for other states of chronic inflammation.
晚期Toll样受体(TLR)配体及其在调节先天性免疫反应中的作用已受到广泛关注。它们作为外源性危险信号,在告知和驱动对病原体的远端适应性免疫反应中起重要作用。在基因毒性或代谢应激(如在逐渐生长的肿瘤中发生的那样)后,应激细胞释放并识别的名义内源性危险信号的作用尚不清楚。高迁移率族蛋白B1(HMGB1)是一种核蛋白,因其能够修饰DNA与转录蛋白的结合而被充分表征,它从坏死细胞中释放出来,并通过造血细胞的内体途径分泌,是脓毒症的晚期介质。它与高亲和力的晚期糖基化终产物受体(RAGE)和TLR2受体相互作用。在这里,我们表明HMGB1可增强巨噬细胞(而非树突状细胞)刺激的自然杀伤细胞释放干扰素γ。只有当与其他促炎细胞因子,特别是与IL-2联合IL-1或IL-12时,这种作用才有效。我们利用这些信息表明,HMGB1在促进上皮迁移和增殖的同时,在其他因素缺失或受到抑制时驱动修复,但在其他因素存在时会增强炎症。这对肿瘤发生和肿瘤进展的影响非常重要,就像它们对其他慢性炎症状态的影响一样。